IOVA

NASDAQ HEALTHCARE

Iovance Biotherapeutics Inc

$9.36

$0.10 (+1.08%)

Live quote

52w: $1.76 – $9.41

Loading chart…

P/E Ratio—

P/B Ratio5.70

EV/EBITDA—

Debt/Equity—

ROE-53.12%

ROIC—

Revenue Growth60.60%

Gross Margin—

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

Own IOVA? Track it here.

Create a free account to add IOVA to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account